Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-032499
Filing Date
2022-05-27
Accepted
2022-05-27 16:09:35
Documents
1
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4187
  Complete submission text file 0001209191-22-032499.txt   5549
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Issuer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22 GLEDHOW GARDENS FLAT 2 LONDON X0 SW5 0AZ
Business Address
Chaya Moghrabi Dina (Reporting) CIK: 0001822418 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39594 | Film No.: 22977477